The preliminary therapeutic evidence, along with the potential pharmacological advantages of 5?MeO?DMT compared to other classical psychedelics, has demonstrated intriguing to researchers and pharmaceutical businesses alike, fueling a escalating quantity of clinical trials which are now in several stages of improvement (Table 1). At the moment, tw